Sold in two forms: an omega-6 rich version carries nearly all the evidence; the other resembles olive oil. The omega-6 form lowers cholesterol more reliably than any other common cooking fat, and improves blood sugar, waist size and blood pressure in people already unwell. One unexplained safety signal sits with existing heart disease. Cheap; rewards cool storage and gentle heat. (Full Review)

Protocol

Standard supplemental dose

8 g/day

High-linoleic form, roughly 1.5 teaspoons, with meals for 12–16 weeks

Culinary substitution approach

15–30 mL/day

Replacing butter, lard or coconut oil rather than added on top

Single dose or split

Split

Divided across the day with meals; reduces gastrointestinal complaints

Time to effect

Blood lipids

4–12 weeks

LDL and total cholesterol; first repeat panel at 12 weeks

Blood sugar, insulin sensitivity and inflammation

16 weeks

HbA1c and C-reactive protein; four months before judging

Blood pressure

12 weeks

Systolic and diastolic fall in metabolic syndrome

Benefits

High: Lower LDL and total cholesterol; improved glycaemic control and insulin sensitivity; reduced abdominal adiposity

Medium: Lower blood pressure

Low: Reduced systemic inflammation; preserved lean muscle mass; improved scar and stretch-mark appearance

Speculative: Mitochondrial cardiolipin remodelling

Contraindications

Asteraceae (daisy family) allergy, unrefined or cold-pressed oil at any dose

Coronary heart disease (especially myocardial infarction within 90 days), supplemental doses

Pregnancy and breastfeeding, concentrated Carthamus tinctorius preparations (culinary oil unrestricted)

Bleeding disorders, INR above 3.0, or surgery within 14 days, at supplemental doses

Key Interactions

Warfarin and other anticoagulants; antiplatelets (clopidogrel, ticagrelor, prasugrel); aspirin, ibuprofen

Insulin, sulfonylureas (glipizide, glyburide, gliclazide)

Antihypertensives (ACE inhibitors, calcium channel blockers)

Glucose- or pressure-lowering supplements (berberine, magnesium, aged garlic)

Orlistat (weight-loss drug)

Evening primrose, borage, blackcurrant seed oils; conjugated linoleic acid

Fish oil and algal omega-3 supplements

Statins or ezetimibe; very-low-carbohydrate and ketogenic diets

Risk & Side Effects

Medium: Increased mortality in secondary prevention

Low: Allergic reactions in daisy-family-sensitive people; additive blood-sugar lowering with diabetes treatment

Speculative: Aldehyde formation during high-heat cooking; shift in the omega-6 to omega-3 balance

Monitoring

Marker	Target	Why
LDL cholesterol	< 100 mg/dL; < 70 with artery disease	Moves most reliably
Apolipoprotein B	< 80 mg/dL	Counts plaque-forming particles LDL can under-read
HbA1c	4.8–5.4%	The sixteen-week glycaemic readout
Fasting glucose	75–85 mg/dL	Earliest glycaemic marker; hypoglycaemia guard
Fasting insulin	2–5 µIU/mL	Insulin resistance shifts before glucose
High-sensitivity C-reactive protein	< 1.0 mg/L	Inflammatory effect, only at raised baselines
Omega-3 index	8–12% of red-cell fatty acids	Direct check on omega-3 displacement
ALT	< 25 U/L men, < 20 U/L women	Fatty liver often accompanies insulin resistance
Waist circumference	< 94 cm men, < 80 cm women	Moved in both body-composition trials
Seated blood pressure	110–120 / 70–80 mmHg	Metabolic-syndrome effect; hypotension guard

Cadence: Baseline; lipids and blood pressure at 12 weeks; HbA1c and omega-3 index at 16 weeks; every 6–12 months thereafter. Fasting glucose at 4 weeks on glucose-lowering medication.

Qualitative Assessment

Late-afternoon energy stability, which tends to follow improved glucose handling
Digestive tolerance; added oil can loosen stools at the supplemental dose
Rancid or paint-like taste, the practical signal of oxidation
Bruising or gum bleeding, the early additive antiplatelet sign
Waistband fit, which registers redistribution before scale weight

Safflower Oil for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment